A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Hunan Cancer Hospital, Changsha, Hunan Last updated November 2024